What Is GMP in an IPO?
GMP, or Grey Market Premium, is the extra amount buyers are willing to pay over an IPO's official issue price, in an informal market that runs alongside the regular application process. If a share is priced at ₹350 and trading at a GMP of ₹40, someone in the grey market is willing to pay ₹390 for the right to that share before it even lists on the NSE or BSE.
This market exists because there's a real gap in an IPO's timeline. Once you apply, several days pass between the issue closing and the stock actually listing, and popular IPOs are often oversubscribed many times over. GMP is the price at which people bet, informally, on how the stock will trade once that gap closes.
Key takeaway: GMP is a same-day mood reading from an unregulated corner of the market, not a confirmed forecast. Treat it as one input, never the reason to apply.
How Is the Estimated Listing Price Calculated From GMP?
GMP gets added straight to the issue price to produce the number every IPO tracker quotes as the "expected listing price."
Estimated Listing Price = Issue Price + GMP
- Issue Price
- The price the company has fixed for the IPO
- GMP
- The current grey market premium, in rupees per share
Say Priya, a first-time IPO applicant in a Tier-2 town, is tracking an IPO priced at ₹350 a share. A GMP tracker shows a premium of ₹45, so the estimated listing price works out to ₹395, about a 12.9% premium over the issue price. That's the number that shows up on every GMP website and every forwarded WhatsApp message about the IPO.
What it isn't: a quote from the exchange, a number any broker will honor, or anything a regulator has signed off on. It's the average of whatever a loose, informal network of traders is currently willing to pay, and that number can move by the hour right up to listing day.
What Are Kostak Price and Subject to Sauda in an IPO?
Two more terms show up alongside GMP, and people mix them up constantly. Kostak price is a flat amount paid for your IPO application itself, regardless of whether you actually get allotted shares. Subject to Sauda is a deal on the shares themselves, and it only completes if you actually receive an allotment. If you get zero shares, the deal is off.
The difference matters because the two carry different risk. Selling at the Kostak price locks in a fixed profit whether or not you're allotted shares. A Subject to Sauda deal only pays out if allotment happens, so the buyer is taking on your allotment risk along with the market's mood.
Is IPO GMP Legal in India?
Grey market trading in India is unregulated, not illegal. SEBI, NSE, and BSE don't recognise, monitor, or enforce any part of it.
That distinction matters more than it sounds. Because there's no exchange, no clearing house, and no contract note behind a grey market deal, there's also no one to complain to if the other side doesn't pay up or backs out. Every grey market transaction runs on the counterparty's word and a broker-dealer network's reputation, nothing else.
Is GMP a Reliable Predictor of Listing Gains?
Not reliably enough to act on by itself. GMP tends to get the listing direction right more often than it gets it wrong, but it has a well-documented habit of overstating the size of the move, and it has been flat-out wrong on some of the country's most closely watched IPOs.
Paytm's 2021 IPO is the clearest example. Days before listing, GMP was pricing in only a modest premium of about 1.4% over the ₹2,150 issue price, implying a listing near ₹2,180. The stock actually listed at ₹1,950, a 9.3% loss on day one, and kept falling from there. The grey market got more than the magnitude wrong here. It called the wrong direction entirely.
LIC's 2022 IPO shows the opposite failure mode: right direction, wrong size. Early in the subscription window, GMP stood near ₹85, implying a listing well above the ₹949 issue price. By the time the issue closed, sentiment had flipped hard, and GMP had swung to a discount of ₹15 to ₹20 in the final days. The stock listed close to 9% below its issue price. The late, pessimistic GMP got the direction right. It just didn't come close to how sharp the fall actually was.
Data backs this up at scale. One analysis of India's 2025 mainboard IPOs found that 56 of 101 issues, more than half, listed below what their grey market premium had implied. GMP is a real signal, drawn from people who often have money riding on the outcome. It isn't a reliable one.
GMP Points Up, Stock Lists Up
The common case. Positive grey market sentiment carries through to a genuine listing-day gain.
GMP Points Up, Stock Lists Down
Paytm's 2021 IPO: GMP implied a roughly 1.4% gain, the stock listed 9.3% below issue price.
GMP Points Down, Stock Lists Up
Happens when last-minute institutional demand or a strong broader market day lifts a stock the grey market had written off.
GMP Points Down, Stock Lists Down
LIC's 2022 IPO: GMP turned negative in the final days, and the stock listed nearly 9% below issue price, in the same direction but a much sharper drop.
What Affects IPO GMP?
GMP isn't set by any formula. It moves with whatever is shaping sentiment around the issue at that moment.
- Subscription numbers. How many times an IPO is subscribed, especially among institutional (QIB) and high-net-worth individual (HNI) bidders, is one of the biggest swing factors. Heavy institutional demand tends to push GMP up; a weak QIB book drags it down fast.
- Anchor investor allocation. A strong anchor book (the shares allotted to big institutions a day before the IPO opens to the public) signals institutional confidence and usually lifts GMP.
- Sector mood. An IPO in a sector currently in favour, a hot new-age tech listing, say, tends to carry a richer GMP than a similar-quality issue in an unloved sector.
- Broader market conditions. A sharp Nifty or Sensex fall in the days before listing can knock several rupees off GMP overnight, independent of anything about the company itself. This is close to what happened to LIC.
- Sheer chatter. With no order book, no depth, and often just a handful of active dealers, GMP for smaller or SME IPOs can swing on rumour and a few low-volume trades alone.
How Should You Use GMP Without Over-Relying on It?
If you're going to look at GMP at all, look at it alongside these, not instead of them.
- Check subscription data by category, not just the headline number. An IPO subscribed 40 times overall but barely covered in the QIB category is a different story from one where institutions are the ones piling in.
- Track GMP over several days, not a single snapshot. A GMP that's been climbing steadily reads differently from one that spiked once and has been falling since, the way LIC's did.
- Read the market mood on listing day itself, not just the day you applied. A GMP quoted a week before listing can be stale by the time the stock actually lists, especially if the broader market moved in between.
- Treat GMP as a mood indicator, not a target price. It tells you what a small, informal group of traders currently feels. It doesn't tell you what the exchange will actually print.
- Don't apply to an IPO purely because GMP is high. Read the company's fundamentals, the price band, and your own reason for wanting the shares first. GMP, at best, is a tiebreaker, not the reason.
Common Misunderstandings
A high GMP guarantees listing gains.
GMP is sentiment from an unregulated market. Paytm had a positive GMP right before listing and still listed down 9.3%.
Grey market IPO trading is illegal in India.
SEBI doesn't regulate it, but that doesn't make it illegal. There's just no legal recourse if a deal falls through.
GMP is a fixed number once it's quoted.
GMP changes hour to hour and can swing hard in the final days, the way LIC's went from a ₹85 premium to a ₹15-20 discount in under two weeks.
Kostak price and GMP mean the same thing.
GMP is the premium on the shares themselves. Kostak is a flat payment for your application, paid regardless of whether you're allotted any shares at all.